Skip to main content
OpenTrials
Completed

NCT Number: NCT01905904

Sevoflurane in Electroconvulsive Therapy

The purpose of the study was to investigate the effects of different doses of sevoflurane used in electroconvulsive therapy (ECT) on duration of seizure, hemodynamic response and recovery profiles

Completed

Looking for future studies?

Notify Me

Key information

Conditions

ECT Anesthesia Nervous System Diseases Neurologic Manifestations Pathological Conditions, Signs and Symptoms Seizures Signs and Symptoms

Age range

18 year–60 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

Inonu Unıversity School of Medicine

Malatya, 44100, Turkey (Türkiye)

About this study

Motor (EMG) and electroencephalography seizure duration (EEG), heart rate (HR) and mean arterial pressure (MAP) values, and recovery times were recorded.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Study included 25 patients of American Society of Anesthesiologists (ASA) physical status I-II aged between 18-60 years who were scheduled for ECT sessions under general anesthesia

Exclusion criteria

  • Pregnancy
  • Cerebrovascular disease
  • Epilepsy
  • Unstable cardiovascular disease
  • Chronic obstructive pulmonary disease; and
  • Renal or hepatic failure

Treatment and study plan

sevorane

Drug

Sevorane 4% Sevorane 7%

Other names: Sevoflurane

Primary outcomes

  1. sevoflurane used in electroconvulsive therapy (ECT) on duration of seizure

    Time frame: taken prior to the seizure

Secondary outcomes

  1. sevoflurane used in electroconvulsive therapy (ECT) on hemodynamic response.

    Time frame: taken prior to the seizure

Sponsors and collaborators

Lead sponsor

Inonu University

Other

Registry information

Official study title

The Comparision of Different Doses of Sevoflurane for Induction of General Anesthesia in Electroconvulsive Therapy

Important dates

Study start
2013
Primary completion
2013
Study completion
2013
First posted
Jul 23, 2013
Registry last updated
May 16, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.